Callan Family Office LLC Buys New Position in Molina Healthcare, Inc $MOH

Callan Family Office LLC purchased a new position in shares of Molina Healthcare, Inc (NYSE:MOH) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 1,008 shares of the company’s stock, valued at approximately $300,000.

Several other hedge funds have also recently made changes to their positions in the company. Price T Rowe Associates Inc. MD raised its stake in shares of Molina Healthcare by 46.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 3,838,043 shares of the company’s stock valued at $1,264,214,000 after buying an additional 1,216,903 shares during the period. T. Rowe Price Investment Management Inc. grew its position in Molina Healthcare by 8.6% during the first quarter. T. Rowe Price Investment Management Inc. now owns 1,487,896 shares of the company’s stock worth $490,099,000 after buying an additional 117,796 shares in the last quarter. AQR Capital Management LLC raised its position in shares of Molina Healthcare by 42.7% during the 1st quarter. AQR Capital Management LLC now owns 884,958 shares of the company’s stock valued at $288,125,000 after buying an additional 264,664 shares in the last quarter. Durable Capital Partners LP raised its position in shares of Molina Healthcare by 13.1% during the 1st quarter. Durable Capital Partners LP now owns 541,605 shares of the company’s stock valued at $178,399,000 after buying an additional 62,899 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in shares of Molina Healthcare by 1.5% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 465,672 shares of the company’s stock worth $153,388,000 after purchasing an additional 7,021 shares in the last quarter. 98.50% of the stock is currently owned by institutional investors.

Molina Healthcare Stock Performance

Shares of MOH opened at $188.26 on Friday. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.66 and a quick ratio of 1.66. Molina Healthcare, Inc has a one year low of $151.95 and a one year high of $359.97. The firm has a market capitalization of $10.20 billion, a P/E ratio of 9.28 and a beta of 0.55. The business has a fifty day moving average of $181.22 and a 200 day moving average of $245.68.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings data on Wednesday, July 23rd. The company reported $5.48 EPS for the quarter, missing the consensus estimate of $5.50 by ($0.02). The firm had revenue of $11.43 billion during the quarter, compared to the consensus estimate of $10.94 billion. Molina Healthcare had a return on equity of 27.72% and a net margin of 2.60%.The business’s revenue was up 15.7% on a year-over-year basis. During the same period in the previous year, the firm earned $5.86 EPS. As a group, sell-side analysts anticipate that Molina Healthcare, Inc will post 24.4 EPS for the current year.

Insider Activity

In other Molina Healthcare news, COO James Woys acquired 10,000 shares of the stock in a transaction dated Monday, August 4th. The shares were acquired at an average cost of $155.94 per share, for a total transaction of $1,559,400.00. Following the completion of the transaction, the chief operating officer directly owned 74,331 shares of the company’s stock, valued at approximately $11,591,176.14. The trade was a 15.54% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Ronna Romney sold 700 shares of the business’s stock in a transaction dated Wednesday, August 6th. The shares were sold at an average price of $153.74, for a total value of $107,618.00. Following the completion of the transaction, the director owned 17,131 shares in the company, valued at $2,633,719.94. The trade was a 3.93% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.10% of the stock is owned by insiders.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the company. Wall Street Zen cut Molina Healthcare from a “buy” rating to a “hold” rating in a report on Sunday, June 29th. JPMorgan Chase & Co. dropped their price objective on Molina Healthcare from $272.00 to $184.00 and set a “neutral” rating for the company in a report on Tuesday, July 29th. Mizuho decreased their target price on Molina Healthcare from $400.00 to $330.00 and set an “outperform” rating for the company in a research report on Friday, July 11th. Truist Financial set a $210.00 target price on Molina Healthcare in a research note on Tuesday. Finally, Barclays reduced their price objective on Molina Healthcare from $186.00 to $185.00 and set an “equal weight” rating for the company in a research report on Thursday, September 4th. Three analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $222.15.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.